# Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination

> **NCT05414890** · — · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 2500 (estimated)

## Conditions studied

- NMO Spectrum Disorder
- NMDA-R Encephalitis
- Diagnostic Self Evaluation
- Immune System Diseases
- Nervous System Diseases
- Autoimmune Diseases of the Nervous System
- Autoimmune Diseases

## Interventions

- **DIAGNOSTIC_TEST:** CBA-TSA

## Key facts

- **NCT ID:** NCT05414890
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-30
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2022-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414890, "Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05414890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*